Immunomedics Inc (NASDAQ:IMMU) - Share price


Stock Report

Immunomedics Inc IMMU

Last Price
$17.54

Day Change
0.24|1.39%

As of 15/11/2019
17:19:21 EST | USD
Minimum 15 Minutes Delay.

Last Close17.30
Day Range17.21 - 17.82
Mkt Cap3.39Bil
52-Wk Range11.55 - 21.23
Yield %-
ISINUS4529071080
Volume1,524,988
P/E-7.89
P/S2,500.00
P/CF-20.80

Share Price

Financials
201620172018
More ...
Income Statement
Revenue3.233.092.16
Operating Income-59.01-79.15-141.05
Net Income-59.04-153.21-273.84
Basic EPS-0.62-1.47-1.78
Avg. Diluted Shares Outstanding95105153
Balance Sheet
Current Assets52.95157.30648.38
Non Current Assets4.005.2815.79
Total Assets56.95162.57664.17
Current Liabilities15.42122.2443.74
Total Liabilities114.48222.04264.49
Total Equity-56.82-58.69400.51
Cash Flow
Operating Cash Flow-48.46-62.25-133.95
Capital Expenditure-2.23-1.84-9.97
Free Cash Flow-50.69-64.09-143.93

In millions, except "Basic EPS". Currency is USD.

Company Profile

Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

346
Key Stats
More ...
Price/Earning TTM-15.04
Price/Book137.30
Price/Sales TTM2,011.63
Rev Growth (3 year avg)-27.48
EPS Growth (3 year avg)-
Operating Margin % TTM-6,542.09
Net Margin % TTM-12,701.18
ROE TTM-160.23
Debt/Equity0.55
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.